Linked e-resources
Details
Table of Contents
Foreword; Foreword; Contents; Part I: The Basis of Integration; 1: Herbal Medicine in Cardiology; 1.1 Primary Cardiological Herbs; 1.2 Metabolic Herbs; 1.3 Nervous Sedation and Neurovegetative Herbs; 1.4 Allium sativum (Garlic); 1.5 Arnica montana; 1.6 Astragalus membranaceus; 1.7 Berberine; 1.8 Camelia sinensis (Green Tea); 1.9 Commiphora mukul (Guggul); 1.10 Convallaria majalis (Lily of the Valley); 1.11 Crataegus oxyacantha (Hawthorn); 1.12 Cytisus scoparius (Broom); 1.13 Digitalis purpurea; 1.14 Gelsemium sempervirens (Yellow Jasmine); 1.15 Ginkgo biloba
1.16 Hibiscus sabdariffa (Roselle)1.17 Leonorus cardiaca (Motherwort); 1.18 Lycopus virginicus/europeus; 1.19 Nattokinase (Fermented Soybeans); 1.20 Plectranthus barbatus (Forskolin); 1.21 Rauvolfia serpentina (Indian Snakeroot); 1.22 Ruscus aculeatus (Butcherś Broom); 1.23 Salvia miltiorrhiza (Danshen); 1.24 Scilla maritima; 1.25 Strophantus kombe; 1.26 Terminalia arjuna; 1.27 Viscum album (Mistletoe); References; 2: Homeopathy and Cardiovascular Disease; 2.1 Historical Background and Basic Concepts; 2.2 Regional Homeopathic Remedies for the Heart; 2.2.1 Aconitum napellus
2.2.2 Adonis vernalis2.2.3 Apocinum cannabinum Injeel; 2.2.4 Arnica montana; 2.2.5 Arsenicum album; 2.2.6 Aurum metallicum; 2.2.7 Baryta carbonica; 2.2.8 Cactus grandiflorus; 2.2.9 Carbo vegetabilis Injeel; 2.2.10 Chininum arsenicosum; 2.2.11 Coffea cruda; 2.2.12 Digitalis purpurea; 2.2.13 Gelsemium sempervirens; 2.2.14 Glonoine; 2.2.15 Grindelia robusta; 2.2.16 Kali carbonicum; 2.2.17 Kalmia latifolia; 2.2.18 Iberis amara; 2.2.19 Lachesis mutus; 2.2.20 Latrodectus mactans; 2.2.21 Naja tripudians; 2.2.22 Prunus spinosa Injeel; 2.2.23 Spigelia marilandica; 2.2.24 Sumbul; 2.2.25 Tabacum
2.2.26 Veratrum albumReferences; 3: Low-Dose Therapy for the Treatment of Low-Grade Chronic Inflammation; 3.1 Introduction; 3.2 Gastrointestinal Homeostasis, Microbiota Composition and Low-Grade Chronic Inflammation; 3.3 Cardiovascular Risk Factors and Low-Grade Chronic Inflammation; 3.4 The Prognostic Role of IL-6 in LGCI and Related Cardiovascular and Kidney Diseases; 3.5 LGCI, Gut-Liver Axis and PNEI Homeostasis Breakdown; 3.6 The Cellular Target of LGCI: Impaired Mitochondrial Activity and Reflexes in Cardiovascular Dysfunction; 3.7 Low-Dose Therapy for the Treatment of LGCI
3.8 Low-Dose Therapy for the Enhancement of Mitochondrial FunctionsReferences; 4: Acupuncture in Cardiovascular Diseases; 4.1 Historical Background, the Beginning and the Diffusion; 4.2 Acupuncture in Cardiovascular Diseases; 4.2.1 Introduction; 4.2.2 Physiology and Pathology; 4.2.3 Cardiovascular Pathological Conditions: Evidence; 4.3 Hypertension; 4.3.1 Hypertension in TCM; 4.3.2 Acupuncture; 4.4 Myocardial Infarction and Coronary Heart Disease; 4.4.1 Coronary Heart Disease in TCM; 4.4.2 Acupuncture; 4.5 Rhythm Disorders; 4.5.1 Arrhythmias in TCM; 4.5.2 Acupuncture; 4.6 Conclusion
1.16 Hibiscus sabdariffa (Roselle)1.17 Leonorus cardiaca (Motherwort); 1.18 Lycopus virginicus/europeus; 1.19 Nattokinase (Fermented Soybeans); 1.20 Plectranthus barbatus (Forskolin); 1.21 Rauvolfia serpentina (Indian Snakeroot); 1.22 Ruscus aculeatus (Butcherś Broom); 1.23 Salvia miltiorrhiza (Danshen); 1.24 Scilla maritima; 1.25 Strophantus kombe; 1.26 Terminalia arjuna; 1.27 Viscum album (Mistletoe); References; 2: Homeopathy and Cardiovascular Disease; 2.1 Historical Background and Basic Concepts; 2.2 Regional Homeopathic Remedies for the Heart; 2.2.1 Aconitum napellus
2.2.2 Adonis vernalis2.2.3 Apocinum cannabinum Injeel; 2.2.4 Arnica montana; 2.2.5 Arsenicum album; 2.2.6 Aurum metallicum; 2.2.7 Baryta carbonica; 2.2.8 Cactus grandiflorus; 2.2.9 Carbo vegetabilis Injeel; 2.2.10 Chininum arsenicosum; 2.2.11 Coffea cruda; 2.2.12 Digitalis purpurea; 2.2.13 Gelsemium sempervirens; 2.2.14 Glonoine; 2.2.15 Grindelia robusta; 2.2.16 Kali carbonicum; 2.2.17 Kalmia latifolia; 2.2.18 Iberis amara; 2.2.19 Lachesis mutus; 2.2.20 Latrodectus mactans; 2.2.21 Naja tripudians; 2.2.22 Prunus spinosa Injeel; 2.2.23 Spigelia marilandica; 2.2.24 Sumbul; 2.2.25 Tabacum
2.2.26 Veratrum albumReferences; 3: Low-Dose Therapy for the Treatment of Low-Grade Chronic Inflammation; 3.1 Introduction; 3.2 Gastrointestinal Homeostasis, Microbiota Composition and Low-Grade Chronic Inflammation; 3.3 Cardiovascular Risk Factors and Low-Grade Chronic Inflammation; 3.4 The Prognostic Role of IL-6 in LGCI and Related Cardiovascular and Kidney Diseases; 3.5 LGCI, Gut-Liver Axis and PNEI Homeostasis Breakdown; 3.6 The Cellular Target of LGCI: Impaired Mitochondrial Activity and Reflexes in Cardiovascular Dysfunction; 3.7 Low-Dose Therapy for the Treatment of LGCI
3.8 Low-Dose Therapy for the Enhancement of Mitochondrial FunctionsReferences; 4: Acupuncture in Cardiovascular Diseases; 4.1 Historical Background, the Beginning and the Diffusion; 4.2 Acupuncture in Cardiovascular Diseases; 4.2.1 Introduction; 4.2.2 Physiology and Pathology; 4.2.3 Cardiovascular Pathological Conditions: Evidence; 4.3 Hypertension; 4.3.1 Hypertension in TCM; 4.3.2 Acupuncture; 4.4 Myocardial Infarction and Coronary Heart Disease; 4.4.1 Coronary Heart Disease in TCM; 4.4.2 Acupuncture; 4.5 Rhythm Disorders; 4.5.1 Arrhythmias in TCM; 4.5.2 Acupuncture; 4.6 Conclusion